The Zacks Analyst Blog Highlights: ConocoPhillips, Sunoco, ExxonMobil, Chevron and Athenahealth

CHICAGO, Sept. 29, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: ConocoPhillips (NYSE: COP), Sunoco Inc. (NYSE: SUN), ExxonMobil Corp. (NYSE: XOM), Chevron Corp. (NYSE: CVX) and Athenahealth (Nasdaq: ATHN).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Wednesday's Analyst Blog:

Conoco to Shed Trainer Refinery

ConocoPhillips (NYSE: COP) plans to either sell or close its refinery unit in Trainer, Pennsylvania, as well as associated pipelines and terminals, after being unable to cope with foreign imports, lower fuel demand and strict regulations. The move also reminds us of the U.S. oil company's objective to get rid of unprofitable refinery units.

The company's intent was made more obvious by its decision to immediately idle the facility and eventually permanently close the Trainer refinery, should it fail to ink any divestiture agreement within six months. The proposed sale would result in a non-cash asset impairment charge of about $300 million in the third quarter of 2011. Plus the closure would make the East Coast more dependent on energy imports from Europe and Eastern Canada.

The Trainer refinery –– located on Delaware River in Trainer, Pennsylvania –– processes 185 thousand barrels of mainly light, low-sulfur crude oil daily. The unit receives crude oil from West Africa and Canada and generates high proportions of transportation fuels, such as gasoline, diesel fuel and jet fuel, along with home heating oil, residual fuel oil and liquefied petroleum gas. It mainly serves Pennsylvania, New York and New Jersey.

Conoco has the same plan for its Bayway refinery, located on New York Harbor in Linden, New Jersey. This facility processes 285 thousand barrels mainly light and low-sulfur crude oil per day. It distributes its refined products to East Coast customers and receives the crude from the North Sea, Canada and West Africa.

In recent times, the East Coast refinery units have been experiencing poorer margins because the companies are finding it more expensive to remain competitive. Sunoco Inc. (NYSE: SUN) also intends to sell or idle its 500 thousand barrels per day Marcus Hook and Philadelphia refineries in Pennsylvania.

Conoco, which remains busy to spin off its refinery unit by next year, continues to be optimistic on its ability to generate free cash flow by unlocking capital tied up in non-core assets. The idea behind the spin-off is to create value for shareholders who like the volatility in the refining business. Creation of two separate companies is also believed to be helpful in ways that the two arms will get to pursue greater opportunities in their respective market segments, without the constraints of the parent company, and better serve the needs of both investor groups. We are also hopeful of a narrower return gap that the company has been facing historically.

However, the company's performances are weighed down by unpredictable global economic conditions and uncertain oil and natural gas prices. Hence, we maintain our long-term Neutral recommendation on ConocoPhillips, the third-largest U.S. oil company by market value after ExxonMobil Corp. (NYSE: XOM) and Chevron Corp. (NYSE: CVX).

Athenahealth Initiated at Outperform

We initiate our coverage on Athenahealth (Nasdaq: ATHN), a leading provider of electronic health record ("EHR") for medical establishments, with an Outperform rating. Second-quarter fiscal 2011 earnings per share of 14 cents beat the Zacks Consensus Estimate of 11 cents. Revenues of $78 million came in ahead of the Zacks Consensus Estimate of $75 million.

The company's web-based deployment provides a low-cost scalable service while its flexible rules engine leads to higher efficiency in claims settlement. The Software-as-a-Service (SaaS)-based approach allows for a more flexible delivery mechanism that is expected to help Athenahealth win deals. The company has traditionally enjoyed high customer satisfaction rates, which facilitate a larger number of referrals.

Athenahealth's unique business model makes it a strong provider of revenue cycle management ("RCM") services (athenaCollector) to small physician practices. Its EHR product (athenaClinical) is a key player in ambulatory settings.  We believe that sales of athenaClinical are likely to remain robust, given the opportunity for physicians to earn incentive payments under the federal stimulus (HITECH provisions).

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
[email protected]
http://www.zacks.com

SOURCE Zacks Investment Research, Inc.